Advances in understanding bone cancer pain
- 7 September 2005
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 96 (4) , 682-688
- https://doi.org/10.1002/jcb.20589
Abstract
Experimental animal models of bone cancer pain have emerged and findings have provided a unique glimpse into unraveling the mechanism that drives this debilitating condition. Key contributors to the generation and maintenance of bone cancer pain are tumor‐induced osteolysis, tumor itself, and production of nociceptive mediators in the bone‐tumor microenvironment. J. Cell. Biochem.Keywords
This publication has 49 references indexed in Scilit:
- Bisphosphonates: Clinical ExperienceThe Oncologist, 2004
- Bone cancer painCancer, 2003
- Functional Interactions Between Tumor and Peripheral Nerve in a Model of Cancer Pain in the MousePain Medicine, 2001
- Osteoclasts are required for bone tumors to grow and destroy boneJournal of Orthopaedic Research, 1998
- Human Osteoclast Formation and Activity In Vitro: Effects of AlendronateJournal of Bone and Mineral Research, 1998
- The Acid-sensitive Ionic Channel Subunit ASIC and the Mammalian Degenerin MDEG Form a Heteromultimeric H+-gated Na+ Channel with Novel PropertiesJournal of Biological Chemistry, 1997
- Skeletal complications of malignancyCancer, 1997
- Prostate cancer. Technology versus biologyCancer, 1993
- Pain relief in active patients with cancer: analgesic drugs are the foundation of management.BMJ, 1989
- Substance P- and CGRP-immunoreactive nerves in bonePeptides, 1988